BioSpace News Archive

The Silver Storm Wireless Medical Mouse is the only mouse that fully secures patient data and complies with HIPAA regulations via AES128 encryption.

Treatment with TyrNovo’s NT219 in combination with targeted cancer drugs, as well as chemotherapy and immuno-oncology therapies, prevented acquired resistance and reversed resistance of colon, lung and head-and-neck cancers in patient-derived xenograft models

Hovione announced today that in the last year their manufacturing facilities were the object of eight inspections, performed by different Health Authorities.

Sigilon Therapeutics, a biopharmaceutical company that discovers and develops immune-privileged living therapeutic implants, today announced that its Afibromer™ Living Therapeutic candidate SIG-003 has been granted an Advanced Therapy Medicinal Product (ATMP) designation by the Committee for Advanced Therapies of the European Medicines Agency.

Tocagen Inc. reported financial results and business highlights for the fourth quarter and full year ended December 31, 2017.

Dicerna Pharmaceuticals Inc. reported financial and operating results for the fourth quarter and full-year ended December 31, 2017.

Navidea Biopharmaceuticals Inc. announced its financial results for the fourth quarter of 2017. Navidea reported total revenues for the quarter of $395,000.

Tyber Medical LLC announces the launch of TyFix™, an all-in-one extremity joint fixation system.

PrescribeWellness announced that it has partnered with life sciences research consultancy Venebio Group to leverage the company’s new prescription opioid risk assessment tool, Venebio Opioid Advisor™ (VOA).

Study Designed to Enhance Clinical Evidence from INSPIRE Study and Support Potential Humanitarian Device Exemption (HDE) Submission